ClinicalTrialsFinder

Very High Risk Acute Lymphoblastic Leukemia Clinical Trials in Seoul

1 recruitingSeoul, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 2

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation

Very High Risk Acute Lymphoblastic LeukemiaCD19 CAR-T Therapy
Seoul National University Hospital50 enrolled1 locationNCT06247501